The UCLA Anxiety Disorders Group in Los Angeles, CA is a leading research institution focused on non-invasive brain stimulation as a treatment for psychiatric disorders, such as depression, bipolar disorder, obsessive-compulsive disorder (OCD), and mild cognitive impairment (MCI). Their clinical trials using transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) have shown promising results, and they are also exploring the use of low-intensity focused ultrasound pulsation (LIFUP) for conditions like epilepsy, coma, and Alzheimer's Disease. Additionally, their research projects delve into the psychophysiology of social anxiety disorder and the impact of cognitive-behavioral therapy on belief structures. They are committed to advancing the field of neuroscience and providing innovative solutions for mental health challenges.
The UCLA Anxiety Disorders Group is affiliated with the UCLA Semel Institute for Neuroscience and Human Behavior, and their work is independent of the University of California and UCLA. With a focus on research, they strive to improve the understanding and treatment of psychiatric disorders through cutting-edge techniques and translational studies. Their dedication to advancing brain stimulation interventions and exploring the effects of LIFUP on rats with PTSD demonstrates their commitment to finding new approaches to mental health care.
Generated from the website
